ClinicalTrials.Veeva
Menu

Find clinical trials for Non-Hodgkin Lymphoma in Budapest, Budapest

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Lymphoma
B-Cell Lymphoma
Diffuse Large B-Cell Lymphoma
Leukemia
Lymphoid Leukemia
B-Cell Chronic Lymphocytic Leukemia
Cancer

Non-Hodgkin Lymphoma trials near Budapest, Budapest, HUN:

Copanlisib and Rituximab in Relapsed Indolent B-cell Non-Hodgkin's Lymphoma (iNHL) (CHRONOS-3)

The purpose of this study was to evaluate whether copanlisib in combination with rituximab is superior to placebo in combination with rituximab in pr...

Active, not recruiting
Lymphoma,Non-Hodgkin
Drug: Placebo
Drug: Copanlisib (Aliqopa, BAY80-6946)

Phase 3

Bayer
Bayer

Budapest, Hungary and 188 other locations

B-cell Lymphoma is an aggressive and rare cancer of a type of immune cell (a white blood cell responsible for fighting infections). The purp-...

Enrolling
Non-Hodgkin Lymphoma
Drug: Prednisone
Drug: Lenalidomide

Phase 2

Genmab
Genmab

Budapest, Hungary and 74 other locations

in combination with bendamustine and rituximab (BR) compared with placebo plus BR in subjects with previously untreated mantle cell lymphoma....

Active, not recruiting
Lymphoma, Mantle Cell
Drug: Bendamustine
Drug: Placebo

Phase 3

Acerta Pharma
Acerta Pharma

Budapest, Hungary and 227 other locations

purpose of this study is to assess the objective response rate of parsaclisib treatment in participants with relapsed or refractory follicular lymphoma...

Active, not recruiting
Lymphoma
Drug: Parsaclisib

Phase 2

Incyte
Incyte

Budapest, Hungary and 82 other locations

This Phase 3 multinational, randomized, double-blind study is designed to compare the efficacy and safety of the combination of ibrutinib and venetoc...

Active, not recruiting
Mantle-Cell Lymphoma
Drug: Ibrutinib
Drug: Venetoclax

Phase 3

Pharmacyclics
Pharmacyclics

Budapest, Hungary and 119 other locations

Multicenter, open-label, prospective treatment protocol that provides continued access to ibrutinib to subjects who have completed parent ibrutinib s...

Invitation-only
Lymphoma, B-Cell
Lymphoma, Non-Hodgkin
Drug: Ibrutinib

Phase 4

Pharmacyclics
Pharmacyclics

Budapest, Hungary and 97 other locations

in participants with relapsed/refractory diffuse large B-cell lymphoma, who are not eligible for high-dose chemotherapy and autologous stem ...

Enrolling
Diffuse Large B-cell Lymphoma
Genetic: MB-CART2019.1
Drug: R-GemOx or BR plus polatuzumab vedotin

Phase 2

Miltenyi Biotec
Miltenyi Biotec

Budapest, Hungary and 53 other locations

of chronic lymphocytic leukemia (CLL)/ small lymphocytic lymphoma (SLL), Richter's transformation, marginal zone lymphoma (MZL), ma...

Enrolling
Non-Hodgkins Lymphoma
Waldenstroms Macroglobulinaemia
Drug: Nemtabrutinib

Phase 2

Merck Sharp & Dohme (MSD)
Merck Sharp & Dohme (MSD)

Budapest, Hungary and 118 other locations

Follicular Lymphoma (FL) is the second most common B-cell cancer and the most common type of cancer of lymphocytes. Unfortunately, this dise...

Enrolling
Follicular Lymphoma (FL)
Drug: Lenalidomide
Drug: Epcoritamab

Phase 3

Genmab
Genmab

Budapest, Hungary and 253 other locations

B-cell Lymphoma is an aggressive and rare cancer of a type of immune cells (a white blood cell responsible for fighting infections). The pur...

Enrolling
Diffuse Large B-Cell Lymphoma
Drug: Epcoritamab
Drug: Rituximab

Phase 3

Genmab
Genmab

Budapest, Hungary and 293 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems